54 patents currently held
23 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Mar 2027. from the record
Of the 23 now held by other companies, 15 name Plumino Precision Fermentation Holdings Pte Ltd. as their current owner, and 8 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
18
Ending by 2030
Mar 2027
Next term end
45
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Oct 2033 · Medium confidence
Also notable
Ends Nov 2035 · High confidence
Also notable
Ends Sep 2029 · High confidence
Also notable
Ends Feb 2029 · High confidence
Also notable
Ends Mar 2027 · High confidence
Also notable
Ends Aug 2031 · High confidence
Also notable
Ends Mar 2037 · High confidence
Also notable
Ends Oct 2039 · High confidence
Agent for Preventing or Improving Decline in Brain Function
US 10,905,705
Cited by 6 later US patents, top 25% of utility patents granted in 2021 in our data. Protection runs to 2033. A terminal disclaimer caps this term to an earlier patent's.
Administration of Citicoline to Improve Cognitive Performance, Attentional Performance, and Motor Function
US 11,583,546
Granted 2023. Computed term ends 2035.
Rapid-Acting, Blood-Arginine-Level-Increasable Oral Preparation Comprising Citrulline and Arginine
US 8,609,735
The largest patent family in this portfolio, 5 related applications, renewed at 3 of 3 maintenance windows. Protection runs to 2029.
Method for Improving Storage Stability of Glutathione
US 9,918,951
Cited by 11 later US patents, top 25% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2029.
Oral Preparation for Preventing or Improving Skin Dryness
US 8,153,692
Renewed at every maintenance window since the 2012 grant; no more fees are due before its term ends in 2027.
Crystalline Oxidized Glutathione and Production Method Therefor
US 9,000,126
Renewed at every maintenance window since the 2015 grant; no more fees are due before its term ends in 2031.
Crystal of Reduced Glutathione and Method for Producing Same
US 10,774,109
Granted 2020. Computed term ends 2037.
Microorganism Producing Eicosapentaenoic Acid and Method for Producing Eicosapentaenoic Acid
US 11,613,728
Granted 2023. Computed term ends 2039.
Formerly held, still cited
Notable
Ends Jan 2030 · High confidence
Renewed at every maintenance window since the 2013 grant; no more fees are due before its term ends in 2030.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Dec 23 to 25, 2026 · next Dec 23
- 1 fee due Jan 14, 2027The maintenance fee for Process for the Production of Dipeptides by a Dipeptide-Synthesizing Enzyme (US 9,081,199) comes due Jan 14, 2027. Unpaid by Jul 14, 2027, it lapses early.
- 4 fees due Feb 6 to 28, 2027 · next Feb 6
- 2 fees due Mar 1 to 10, 2027 · next Mar 1
- 1 fee due Apr 1, 2027The maintenance fee for Method to Enhance Endurance (US 10,426,813) comes due Apr 1, 2027. Unpaid by Oct 1, 2027, it lapses early.
- 1 fee due Jul 26, 2027The maintenance fee for Crystalline Oxidized Glutathione and Production Method Therefor (US 9,243,029) comes due Jul 26, 2027. Unpaid by Jan 26, 2028, it lapses early.
- 1 fee due Aug 2, 2027The maintenance fee for Process for Production of Reduced Glutathione (US 9,249,517) comes due Aug 2, 2027. Unpaid by Feb 2, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
The largest of its 45 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,153,692 | Oral Preparation for Preventing or Improving Skin Dryness In force · High confidence | In force | High confidence | |
| US 7,932,288 | Composition for Relieving Subjective Symptoms of Fatigue In force · High confidence | In force | High confidence | |
| US 8,685,914 | L-Alanyl-L-Glutamine Crystal In force · High confidence | In force | High confidence | |
| US 8,067,537 | Composition and Method for Treatment of Stomatitis In force · High confidence | In force | High confidence | |
| US 8,188,308 | Crystal of Glutathione and Process for Production Thereof In force · High confidence | In force | High confidence | |
| US 9,060,980 | Rapid-Acting, Blood-Arginine-Level-Increasable Oral Preparation Comprising Citrulline and Arginine In force · High confidence | In force | High confidence | |
| US 9,622,998 | Rapid-Acting, Blood-Arginine-Level-Increasable Oral Preparation Comprising Citrulline and Arginine In force · High confidence | In force | High confidence | |
| US 10,052,298 | Rapid-Acting, Blood-Arginine-Level-Increasable Oral Preparation Comprising Citrulline and Arginine In force · High confidence | In force | High confidence | |
| US 8,679,568 | Citrulline-Containing Beverage In force · High confidence | In force | High confidence | |
| US 9,375,479 | Citrulline Containing Beverage In force · High confidence | In force | High confidence |
Also on record, not counted in the 54: 23 patents in force now held by others · 55 patents ended · 20 applications pending · 75 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.